Jpmorgan Chase & Co »

Ascendis Pharma A S call shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Ascendis Pharma A S call shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Ascendis Pharma A S call

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S call held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S call by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $15M 75k 198.81
2023-09-30 $2.3M 25k 93.64
2023-06-30 $8.9M 100k 89.25
2023-03-31 $8.0M 75k 107.23
2022-03-31 $352k 3.0k 117.33
2020-12-31 $4.5M 27k 166.78
2019-12-31 $5.0M 36k 139.11

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Meta Platforms Common (META)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Broadcom Common (AVGO)
Alphabet Common (GOOG)
Tesla Common (TSLA)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Vanguard S&p 500 Etf Fund (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Oracle Corp Common (ORCL)
Abbvie Common (ABBV)

View all positions for Jpmorgan Chase & Co

Top funds holding Ascendis Pharma A S call

Jpmorgan Chase & Co
Simplex Trading
Group One Trading
IMC-Chicago

View all funds holding Ascendis Pharma A S call